share_log

Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $92 Price Target

Benzinga ·  Sep 20 23:20  · Ratings

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $92 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment